Dr. Markus Jörger über die Highlights des Presidental Symposiums am 10. 9.
This is our swiss expert with an overview of sunday’s Highlights that will be presented at the presidential symposium.
Dr. Markus Jörger vom Kantonspital St. Gallen spricht im Video über die Highlights, die im Presidental Symposium a. 10. 9. präsentiert wurden.
Video in Englisch.
Referenzen:
Di Leo A et al., asbtract 236O_PR: MONARCH 3: Abemaciclib as initial therapy for patients with HR+/HER2- advanced breast cancer
Zum Video mit Dr. Di Leo >>
Gupta S et al., abstract 928O_PR: Neoadjuvant chemotherapy followed by surgery (NACT-surgery) versus concurrent cisplatin and radiation therapy (CTRT) in patients with stage IB2 to IIB squamous carcinoma of cervix: A randomized controlled trial (RCT)
Zum Video mit Dr. Gupta >>
Petrylak D et al., abstract LBA4_PR: RANGE: A randomized, double-blind, placebo-controlled phase 3 study of docetaxel (DOC) with or without ramucirumab (RAM) in platinum-refractory advanced or metastatic urothelial carcinoma
Zum Video mit Dr. Petrylak >>
Escudier B et al., abstract LBA5: CheckMate 214: Efficacy and safety of nivolumab + ipilimumab (N+I) v sunitinib (S) for treatment-naïve advanced or metastatic renal cell carcinoma (mRCC), including IMDC risk and PD-L1 expression subgroups